Aetiology of extracranial carotid free-floating thrombus in a prospective multicentre cohort.


Journal

Stroke and vascular neurology
ISSN: 2059-8696
Titre abrégé: Stroke Vasc Neurol
Pays: England
ID NLM: 101689996

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 09 04 2022
accepted: 19 10 2022
medline: 26 6 2023
pubmed: 12 11 2022
entrez: 11 11 2022
Statut: ppublish

Résumé

Carotid free-floating thrombi (FFT) in patients with acute transient ischaemic attack (TIA)/stroke have a high risk of early recurrent stroke. Management depends on aetiology, which can include local plaque rupture, dissection, coagulopathy, malignancy and cardioembolism. Our objectives were to classify the underlying aetiology of FFT and to estimate the proportion of patients with underlying stenosis requiring revascularisation. We prospectively enrolled consecutive patients presenting to three comprehensive stroke centres with acute TIA/stroke and ipsilateral internal carotid artery FFT. The aetiology of FFT was classified as: carotid atherosclerotic disease, carotid dissection, cardioembolism, both carotid atherosclerosis and cardioembolism, or embolic stroke of uncertain source (ESUS). Patients with carotid atherosclerosis were further subclassified as having ≥50% or <50% stenosis. We enrolled 83 patients with confirmed FFT. Aetiological assessments revealed 66/83 (79.5%) had carotid atherosclerotic plaque, 4/83 (4.8%) had a carotid dissection, 10/83 (12%) had both atrial fibrillation and carotid atherosclerotic plaque and 3/83 (3.6%) were classified as ESUS. Of the 76 patients with atherosclerotic plaque (including those with atrial fibrillation), 40 (52.6%) had ≥50% ipsilateral stenosis. The majority of symptomatic carotid artery FFT are likely caused by local plaque rupture, more than half of which are associated with moderate to severe carotid stenosis requiring revascularisation. However, a significant number of FFTs are caused by non-atherosclerotic mechanisms warranting additional investigations.

Sections du résumé

BACKGROUND BACKGROUND
Carotid free-floating thrombi (FFT) in patients with acute transient ischaemic attack (TIA)/stroke have a high risk of early recurrent stroke. Management depends on aetiology, which can include local plaque rupture, dissection, coagulopathy, malignancy and cardioembolism. Our objectives were to classify the underlying aetiology of FFT and to estimate the proportion of patients with underlying stenosis requiring revascularisation.
METHODS METHODS
We prospectively enrolled consecutive patients presenting to three comprehensive stroke centres with acute TIA/stroke and ipsilateral internal carotid artery FFT. The aetiology of FFT was classified as: carotid atherosclerotic disease, carotid dissection, cardioembolism, both carotid atherosclerosis and cardioembolism, or embolic stroke of uncertain source (ESUS). Patients with carotid atherosclerosis were further subclassified as having ≥50% or <50% stenosis.
RESULTS RESULTS
We enrolled 83 patients with confirmed FFT. Aetiological assessments revealed 66/83 (79.5%) had carotid atherosclerotic plaque, 4/83 (4.8%) had a carotid dissection, 10/83 (12%) had both atrial fibrillation and carotid atherosclerotic plaque and 3/83 (3.6%) were classified as ESUS. Of the 76 patients with atherosclerotic plaque (including those with atrial fibrillation), 40 (52.6%) had ≥50% ipsilateral stenosis.
CONCLUSIONS CONCLUSIONS
The majority of symptomatic carotid artery FFT are likely caused by local plaque rupture, more than half of which are associated with moderate to severe carotid stenosis requiring revascularisation. However, a significant number of FFTs are caused by non-atherosclerotic mechanisms warranting additional investigations.

Identifiants

pubmed: 36368714
pii: svn-2022-001639
doi: 10.1136/svn-2022-001639
pmc: PMC10359789
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-196

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Neuroradiology. 2014 Jan;56(1):15-23
pubmed: 24212333
Int J Stroke. 2013 Jun;8(4):220-7
pubmed: 22494778
Int J Stroke. 2019 Apr;14(3):247-256
pubmed: 30722756
Ann Vasc Surg. 1990 Nov;4(6):558-62
pubmed: 2261324
Stroke. 2019 Feb;50(2):357-364
pubmed: 30595130
Neurology. 2021 Aug 24;97(8):e785-e793
pubmed: 34426550
Can J Neurol Sci. 2022 May;49(3):315-337
pubmed: 34140063
Stroke. 1988 Jun;19(6):681-7
pubmed: 3376159

Auteurs

Dar Dowlatshahi (D)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada ddowlat@toh.ca.
Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Cheemun Lum (C)

Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.

Bijoy K Menon (BK)

Departments of Clinical Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Aditya Bharatha (A)

Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.

Prasham Dave (P)

Medicine, Queen's University, Kingston, Ontario, Canada.

Paulo Puac-Polanco (P)

Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.

Dylan Blacquiere (D)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Grant Stotts (G)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Michel Shamy (M)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Franco Momoli (F)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Rebecca Thornhill (R)

Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.

Ronda Lun (R)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Carlos Torres (C)

Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH